STOCK TITAN

Rockwell Medical (RMTI) CFO has shares withheld to cover taxes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Rockwell Medical Senior Vice President and CFO Jesse Neri reported a routine tax-related share withholding. On the vesting of restricted stock units, 2,444 shares of common stock were withheld at $0.90 per share to cover estimated tax obligations. After this non-market disposition, Neri directly holds 122,398 shares of Rockwell Medical common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neri Jesse

(Last) (First) (Middle)
30142 WIXOM ROAD

(Street)
WIXOM MI 48393

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ROCKWELL MEDICAL, INC. [ RMTI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and CFO
3. Date of Earliest Transaction (Month/Day/Year)
03/14/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/14/2026 F(1) 2,444 D $0.9 122,398 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares were withheld from the vesting of restricted stock units to cover the estimated tax withholding obligation.
Remarks:
/s/ Megan Timmins, Attorney-in-fact for Jesse Neri 03/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Rockwell Medical (RMTI) report for CFO Jesse Neri?

Rockwell Medical reported that CFO Jesse Neri had 2,444 shares of common stock withheld to cover estimated taxes upon the vesting of restricted stock units. This is a non-market tax-withholding event rather than an open-market purchase or sale of shares.

Was the Rockwell Medical (RMTI) CFO’s Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. The 2,444 shares were withheld by the company from vested restricted stock units to satisfy estimated tax obligations, a standard administrative process rather than a discretionary sale in the open market by the CFO.

How many Rockwell Medical (RMTI) shares does CFO Jesse Neri hold after this filing?

Following the tax-withholding disposition, CFO Jesse Neri directly holds 122,398 shares of Rockwell Medical common stock. This figure reflects his position after 2,444 shares were withheld from vested restricted stock units to cover estimated tax liabilities associated with that equity compensation.

What does the F transaction code mean in the Rockwell Medical (RMTI) Form 4?

The F transaction code indicates shares were used to pay an exercise price or tax liability. In this case, 2,444 Rockwell Medical shares were withheld from restricted stock unit vesting to satisfy estimated tax withholding, making it a compensation-related administrative event, not a market trade.

How many Rockwell Medical (RMTI) shares were withheld for taxes in this Form 4?

The filing shows 2,444 shares of Rockwell Medical common stock were withheld. These shares came from the vesting of restricted stock units and were retained by the company to cover the estimated tax withholding obligation associated with that equity compensation event for the CFO.
Rockwell Med Inc

NASDAQ:RMTI

View RMTI Stock Overview

RMTI Rankings

RMTI Latest News

RMTI Latest SEC Filings

RMTI Stock Data

35.31M
34.20M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
WIXOM